Coca-Cola stock inches up after Costa Coffee sale is shelved, leadership reshuffle detailed
14 January 2026
1 min read

Coca-Cola stock inches up after Costa Coffee sale is shelved, leadership reshuffle detailed

New York, January 14, 2026, 14:29 ET — Regular session

  • Coca-Cola shares climbed after the company paused its sale of Costa Coffee and announced changes to its operating leadership
  • Starting March 31, a new chief digital officer will take over duties previously handled by CFO John Murphy
  • Attention shifts to Coca-Cola’s earnings call on Feb. 10 and its investor conference spot on Feb. 17

Coca-Cola shares edged up 0.4% to $71.51 in afternoon trading Wednesday, following news of leadership changes and a report that the company has put its Costa Coffee sale plans on hold.

The Costa decision is significant because it leaves a troubled asset on Coca-Cola’s balance sheet just as investors demand that major consumer companies streamline their portfolios and tighten capital discipline. According to the Financial Times, bids for Costa didn’t meet Coca-Cola’s expectations, leading the company to halt the sale process for the moment. 1

This comes amid a shift back toward defensives. The Consumer Staples Select Sector SPDR Fund gained roughly 1.4%, even as the S&P 500 tracker SPY slipped about 0.8% during that period.

Coca-Cola is overhauling parts of its operating structure as Henrique Braun prepares to take over as CEO at the end of March. “We are evolving our operating organization structure and elevating digital leadership so we can move faster and work smarter across all markets,” Braun said in a statement. 2

A recent U.S. regulatory filing, the 8-K used to report significant corporate developments, detailed the planned shifts. Coca-Cola announced the creation of a chief digital officer position. Sedef Salingan Sahin is slated to take over duties now handled by CFO John Murphy. Meanwhile, Manolo Arroyo will step into an expanded role covering customer and commercial leadership. 3

The Financial Times reported that Coca-Cola halted talks with the last bidders for Costa in December, following a months-long auction process. Reuters noted neither Coca-Cola nor Costa responded immediately to requests for comment and said it couldn’t independently confirm the report. 4

Coca-Cola’s decision to hold Costa sends mixed signals in the short term. Keeping the brand maintains optionality if valuations climb, but it also means management remains tied up with turnaround challenges in a business acquired as a growth play beyond soda.

PepsiCo shares climbed roughly 1.7% today, spotlighting the broader beverage sector as investors assess pricing strength, volume shifts, and input expenses ahead of earnings season.

The downside is clear: if Costa keeps underperforming and Coca-Cola can’t pinpoint a solid way to boost returns—or if the leadership changes throw off execution—the narrative flips from “patience” to “dead money.” Then the market begins factoring in a drawn-out, more complicated turnaround.

Coca-Cola’s next major date is its Q4 2025 earnings call on Feb. 10, with a follow-up at the CAGNY 2026 conference a week later, on Feb. 17. Investors will be eager for updates on Costa, digital spending strategies, and Braun’s approach to leading the company starting March 31. 5

Stock Market Today

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

7 February 2026
Applied Digital Corporation shares jumped 25.52% Friday to $34.95, then slipped to $34.60 after hours. The company reported fiscal Q2 revenue up 250% to $126.6 million and signed leases for 600 MW of data center capacity in North Dakota. Applied Digital broke ground on a new 430‑MW campus in the southern U.S. in January. Financing includes a $100 million promissory note with 8% interest, paid in kind.
Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

7 February 2026
Eli Lilly shares rose 3.7% to $1,058.18 Friday after the FDA said it would act against telehealth firm Hims & Hers for marketing a $49 compounded weight-loss pill. The move followed a sharp selloff Thursday when Hims announced plans to sell a version of Novo Nordisk’s Wegovy. Investors remain uncertain how aggressively regulators will police copycat drugs and pricing in the obesity drug market.
UEC stock jumps nearly 11% as uranium supply squeeze talk returns — and a Feb. 27 vote looms
Previous Story

UEC stock jumps nearly 11% as uranium supply squeeze talk returns — and a Feb. 27 vote looms

CVR Energy stock jumps as oil volatility and U.S. inventory data keep refiners in focus
Next Story

CVR Energy stock jumps as oil volatility and U.S. inventory data keep refiners in focus

Go toTop